임상 레이더 AI | ||
|---|---|---|
임상시험 NCT07493226은(는) 동결견, 유착성 관절낭염, 어깨 통증, NSAID (Non-Steroidal Anti-Inflammatory Drug), 신경가소통증, 신경병성 통증에 대해 모집중 상태입니다. 모든 세부 정보를 보려면 임상시험 레이더 카드 뷰와 AI 발견 도구를 확인하거나 여기에서 무엇이든 물어보세요. | ||
하나의 임상시험이 필터 기준과 일치합니다.
카드 뷰
Efficacy of Chemically Distinct Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) and Pain Phenotypes in Adhesive Capsulitis 120 자택 기반 운동
임상시험 세부 정보는 주로 영어로 제공됩니다. 하지만 임상 레이더 AI가 도와드릴 수 있습니다! '임상시험 설명'를 클릭하여 선택한 언어로 임상시험 정보를 확인하고, 이에 대해 AI와 논의해 보세요.
임상시험 NCT07493226은(는) 동결견, 유착성 관절낭염, 어깨 통증, NSAID (Non-Steroidal Anti-Inflammatory Drug), 신경가소통증, 신경병성 통증에 대해 알아보는 중재연구입니다. 현재 상태는 모집중이며, 연구는 2026년 4월 1일에 시작되어 120명의 참여자를 모집하고 있습니다. Konya Beyhekim Training and Research Hospital이(가) 진행하며, 2027년 3월 30일까지 완료될 예정입니다. ClinicalTrials.gov의 가장 최근 정보는 2026년 3월 25일에 갱신되었습니다.
간단한 개요
Patients aged 18-75 years who present to a tertiary rehabilitation hospital with shoulder pain and restricted range of motion, and who consent to participate, will be included in the study. Eligibility will be determined based on predefined inclusion and exclusion criteria.
Eligible patients will be randomly assigned to receive one of several nonsteroidal anti-inflammatory drugs (NSAIDs) with differing chemical prop...
더 보기상세한 설명
This study will include patients presenting to the Physical Medicine and Rehabilitation outpatient clinics of Konya Beyhekim Training and Research Hospital with shoulder pain and restricted range of motion, who are clinically diagnosed with frozen shoulder following a comprehensive evaluation. All patients will be prescribed non-steroidal anti-inflammatory drugs (NSAIDs) as part of analgesic treatment.
A total of 12...
더 보기공식 제목
Comparative Efficacy of Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) With Distinct Chemical Structures in Shoulder Adhesive Capsulitis and the Role of Pain Phenotypes
질환명
동결견유착성 관절낭염어깨 통증NSAID (Non-Steroidal Anti-Inflammatory Drug)신경가소통증신경병성 통증기타 연구 식별자
- BeyhekimTRH-RHT2026/5477
NCT 번호
실제 연구 시작일
2026-04-01
최신 업데이트 게시
2026-03-25
예상 연구 완료일
2027-03-30
계획된 등록 인원
120
연구종류
중재연구
단계/상
해당 없음
상태
모집중
키워드
frozen shoulder
adhesive capsulitis
shoulder pain
pain phenotypes
exercises
Nonsteroidal Anti-Inflammatory Drugs
adhesive capsulitis
shoulder pain
pain phenotypes
exercises
Nonsteroidal Anti-Inflammatory Drugs
주요 목적
치료
설계 할당
무작위배정
중재 모델
평행설계
맹검 (마스킹)
단일맹검
시험군 / 개입
| 참가자 그룹/시험군 | 개입/치료 |
|---|---|
활성 대조군propionic acid derivatives Patients will be given oral tablets of ibuprofen or naproxen in this group. | Propionic acid deriaves Patients randomized into this group (n=40) will, again by simple randomization, be given oral tablets of ibuprofen or naproxen |
활성 대조군acetic acid derivatives Patients will be given oral tablets of etodolac or diclofenac in this group. | acetic acid derivatives Patients randomized into this group (n=40) will, again by simple randomization, be given oral tablets of etodolac or diclofenac. |
활성 대조군oxicam derivatives Patients will be given oral tablets of meloxicam or lornoxicam in this group. | oxicam derivatives Patients randomized into this group (n=40) will, again by simple randomization, be given oral tablets of meloxicam or lornoxicam. |
주요결과변수
이차결과변수
| 결과변수 | 측정값 설명 | 시간 범위 |
|---|---|---|
VAS pain (0-10) (night and movement) | Visual Analog Scale (VAS) for pain: 0 = no pain, 10 = worst imaginable/unbearable pain. | Baseline, Week 1, and Week 2 |
Range of motion (ROM) | Movements of the affected shoulder (flexion, abduction, internal and external rotation) will be measured and recorded using a goniometer. The presence of limitation will be assessed by comparing it to the unaffected side. | Baseline, and Week 2 |
SPADI :Shoulder Pain and Disability Index | The Shoulder Pain and Functionality Index (SPADI) is a self-report scale developed to assess the severity of shoulder pain and its impact on functionality. The scale consists of two sub-sections: pain (5 items) and functionality (8 items). Each item is scored from 0 (no pain or difficulty) to 10 (unbearable pain or extreme difficulty). The total score ranges from 0 to 100; higher scores indicate more severe pain and loss of function. | Baseline, and Week 2 |
| 결과변수 | 측정값 설명 | 시간 범위 |
|---|---|---|
DN4 Neuropathic Pain Questionnaire | This is a questionnaire that compiles symptoms and findings associated with neuropathic pain. It is scored on a scale of 0-10. A score above 4 is considered indicative of neuropathic pain. | Baseline |
Central Sensitization Inventory | This is a 25-item self-report scale that measures central nervous system hypersensitivity to normal stimuli (central sensitization), a condition that plays a role in the pathophysiology of chronic pain. It aids in diagnosis of chronic pain syndromes such as fibromyalgia by scoring common somatic and emotional symptoms on a scale of 0-100. | Baseline |
Sleep Quality Scale | Sleep quality during the preceding week was evaluated using the Single-Item Sleep Quality Scale (SQS), a brief and practical instrument derived from item 6 of the Pittsburgh Sleep Quality Index. The scale evaluates sleep quality using a VAS ranging from 0 to 10, which is then categorized on a 0-4 scale, ranging from 0 (terrible) to 4 (excellent)." | Baseline, and Week 2 |
Pain Catastrophizing Scale | This is a 13-item self-report questionnaire, scored from 0 to 52, that measures negative cognitive and emotional responses to pain experiences, such as helplessness, exaggeration (magnification), and rumination. It is widely used in chronic pain management and in determining a patient's sensitivity to pain. | Baseline, and Week 2 |
Patient satisfaction (subjective impression of improvement) | Patient satisfaction subjective evaluation is the measurement of a patient's personal perceptions, feelings, and expectations regarding the healthcare service received, physician communication, hospital environment, and treatment outcomes, through surveys or interviews.
Patient satisfaction (subjective impression of improvement) was assessed using a five-point Likert-type scale. Response options were defined as follows: 1, "no satisfaction at all"; 2, "not satisfied"; 3, neutral (no positive or negative effect); 4, "satisfied"; and 5, "very satisfied." | 2nd week |
참여 도우미
적격성 기준
연령대
성인, 노인
최소 연령
18 Years
참여 가능한 성별
전체
- Being between 18-75 years of age
- Having shoulder pain that has lasted for at least one month and being diagnosed with primary frozen shoulder
- Having a VAS pain level ≥ 4/10
- Having ≥30 degrees of range of motion restriction in at least two planes (flexion, abduction, or external rotation)
Exclusion Criteria:
- Patients with a history of shoulder trauma, those with musculoskeletal disorders characterized by pain and loss of function in the affected extremity (such as lateral epicondylitis, flexor tendon injury, de Quervein's tenosynovitis)
- Presence of neurological involvement such as stroke, brachial plexus injury, Parkinson's disease, and cervical spine injury with or without radiculopathy
- History of shoulder surgery, malignancy or tumor in the shoulder, those who have undergone shoulder manipulation
- Presence of shoulder arthritis, rotator cuff tear or other shoulder injuries, thoracic outlet syndrome
- Systemic disease affecting the shoulder region, severe degeneration or trauma (e.g., osteoarthritis, rheumatoid arthritis, history of labrum or articular cartilage injuries), inflammatory rheumatic diseases
- Those who have received steroid injections into the affected extremity within the last 3 months, those using oral steroids or NSAIDs, those receiving any surgical or interventional treatment, or Planned individuals:
- Those who are pregnant or lactating
- Those with uncontrolled diabetes, heart failure, uncontrolled systemic disease (liver disease, chronic kidney failure, significant endocrine disorders, etc.)
- Those with communication problems, severe psychiatric disorders
- Those allergic to NSAIDs or with any contraindications
- Those with bleeding, coagulation disorders, stomach ulcers, or symptomatic gastritis
Konya Beyhekim Training and Research Hospital연구 책임자
Rukiye Hilal Taygurt, 책임연구자, Resident doctor, Konya Beyhekim Training and Research Hospital
연구 대표 연락처
연락처: Rukiye Hilal Taygurt Md., principal investigator, +905389122141, [email protected]
연락처: furkan taygurt Md., relative, +905512203334, [email protected]
1 1개국에 임상시험 장소
Selçuklu
Konya Beyhekim Training and Research Hospital, Konya, Selçuklu, 42000, Turkey (Türkiye)
Konya Beyhekim Training and Research Hospital Physical Therapy and Rehabilitation Center, 연락처, 0332 224 30 00, [email protected]
Rukiye Hilal taygurt Md., principal investigator, 연락처, 05389122141, [email protected]
Rukiye Hilal Taygurt Md., principal investigator, 책임연구자
모집중